Rchr
J-GLOBAL ID:201801005688944074   Update date: Nov. 18, 2024

Yuki Enoki

Yuki Enoki
Research field  (1): Clinical pharmacy
Research theme for competitive and other funds  (2):
  • 2022 - 2025 骨格筋由来エクソソームによるサルコペニア合併敗血症増悪機序の解明
  • 2018 - 2021 Strategy for the treatment of CKD-induced sarcopenia based on the crosstalk between myokine and uremic toxins
Papers (78):
  • Yuki Enoki, Tomoya Nagai, Yuna Hamamura, Sumika Osa, Hideaki Nakamura, Kazuaki Taguchi, Hiroshi Watanabe, Toru Maruyama, Kazuaki Matsumoto. The G protein-coupled receptor ligand apelin-13 ameliorates skeletal muscle atrophy induced by chronic kidney disease. Journal of cachexia, sarcopenia and muscle. 2023. 14. 1. 553-564
  • Marina Itagaki, Osamu Iketani, Yuki Enoki, Victor Tuan Giam Chuang, Kazuaki Taguchi, Shunsuke Uno, Sho Uchida, Ho Namkoong, Yoshifumi Uwamino, Yaoko Takano, et al. Analysis of Risk Factors for Developing Tuberculosis in Patients Who Received Prophylactic Latent Tuberculosis Infection Treatment with Experience of Biologic Medications. Biological & pharmaceutical bulletin. 2023. 46. 12. 1832-1837
  • Tatsuki Hasegawa, Sho Tashiro, Takayuki Mihara, Junya Kon, Kazuki Sakurai, Yoko Tanaka, Takumi Morita, Yuki Enoki, Kazuaki Taguchi, Kazuaki Matsumoto, et al. Efficacy of surgical skin preparation with chlorhexidine in alcohol according to the concentration required to prevent surgical site infection: meta-analysis. BJS Open. 2022. 6. 5
  • Masaru Samura, Yuki Kitahiro, Sho Tashiro, Hiromu Moriyama, Yuna Hamamura, Isamu Takahata, Rina Kawabe, Yuki Enoki, Kazuaki Taguchi, Yoshio Takesue, et al. Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus with Vancomycin Minimum Inhibitory Concentration > 1 μg/mL: A Systematic Review and Meta-Analysis. Pharmaceutics. 2022. 14. 4
  • Kana Misawa, Tomoyasu Nishimura, Shoko Kashimura, Yuki Enoki, Kazuaki Taguchi, Shunsuke Uno, Yoshifumi Uwamino, Kazuaki Matsumoto, Naoki Hasegawa. In vitro effects of diazabicyclooctane β-lactamase inhibitors relebactam and nacubactam against three subspecies of Mycobacterium abscessus complex. International journal of antimicrobial agents. 2022. 60. 5-6. 106669-106669
more...
MISC (7):
more...
Books (5):
  • 「ニガテさん」のための薬物動態
    じほう 2021
  • スペシャル・ポピュレーションの抗菌薬投与設計
    じほう 2020
  • Molecular mechanism of muscle wasting in CKD
    Recent Advances of Sarcopenia and Frailty in CKD 2020 ISBN:9789811523649
  • 調剤と情報-高齢者の低栄養と薬-
    JIHO 2018
  • 新薬展望2018
    Medicine and Drug Journal 2018
Lectures and oral presentations  (66):
  • 一酸化炭素結合型ヘモグロビン小胞体の急性呼吸窮迫症候群に対する有用性評価
    (人工血液 2021)
  • メトヘモグロビン内包リポソームの長期安定性評価
    (人工血液 2021)
  • メトヘモグロビン内包リポソームの新規アジド中毒解毒剤としての有効性評価
    (人工血液 2021)
  • 【難しい数式も、TDMもわからない!「ニガテさん」のための薬物動態】(第4章)患者背景によるADMEの変化に注目できる! 高齢者の薬物動態
    (調剤と情報 2021)
  • ヘモグロビンを担体とした一酸化炭素製剤の閉塞性細気管支炎に対する治療効果の解析
    (日本DDS学会学術集会プログラム予稿集 2021)
more...
Awards (1):
  • 2020/12/08 - 日本医真菌学会 真菌症フォーラム2020奨励賞 カンジダ血症におけるカテーテル抜去の有用性に関する検討:ランダム化比較 試験のサブグループ解析に基づく検証
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page